Seroprevalence of human T-cell leukemia/lymphoma virus type I and type II (HTLV-I/HTLV-II) infection among volunteer blood donors in Kuwait

被引：7

作者：

Al-Mufti, S ^{[1
]}

Voevodin, A ^{[1
]}

Ahmed, S ^{[1
]}

Al Hamdan, S ^{[1
]}

Al-Basheer, AA ^{[1
]}

机构：

[1] Minist Hlth, Publ Hlth Labs, Shaab 36057, Kuwait

来源：

MEDICAL PRINCIPLES AND PRACTICE | 1999年 / 8卷 / 01期

关键词：

human T-cell leukemia/lymphoma virus type I blood donors; antibodies; Western blot; Kuwait; Iran; India;

D O I：

10.1159/000026068

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: The human T-cell leukemia/lymphoma virus type I (HTLV-I) is an etiologic agent of adult T-cell leukemia/lymphoma and tropical spastic paraparesis. One of the major routes of transmission of the virus is through blood transfusion. The aim of this study was to determine the prevalence of HTLV-I infection in volunteer blood donors in Kuwait. Methods: A donation of 97,602 blood units in Kuwait from March 1995 to October 1997 was tested for antibodies against HTLV-I and related virus (HTLV-II). The testing was carried out in three steps: first screening by enzyme immunoassay (EIA) for anti-HTLV-I/II, second testing of initially positive samples by the EIA and final confirmation of true positives by Western blot. Results: Twenty-one HTLV-l-positive donors have been identified (7 Kuwaitis, 5 Indians, 4 Iranians, 2 Bedouins, 1 Omani, 1 Egyptian and 1 Filipino). None of the EIA-reactive samples was positive for HTLV-II by Western blot. The frequency of HTLV-l-positive blood donations was: 1:4,648 and the infection was significantly more prevalent among Indians and Iranians. Conclusion: The prevalence of HTLV-I infection in blood donors in Kuwait is one of the highest in the world and compulsory screening of blood for HTLV-I is fully justified.

引用

页码：45 / 50

页数：6

共 33 条

[1] SPASTIC PARAPARESIS ASSOCIATED WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-I - A CLINICAL, SEROLOGICAL, AND GENOMIC STUDY IN IRANIAN-BORN MASHHADI JEWS [J].

ACHIRON, A ;

PINHASHAMIEL, O ;

DOLL, L ;

DJALDETTI, R ;

CHEN, A ;

ZIV, I ;

AVNI, A ;

FRANKEL, G ;

MELAMED, E ;

SHOHAT, B .

ANNALS OF NEUROLOGY, 1993, 34 (05) :670-675

[2]

AlMufti S, 1997, J ACQ IMMUN DEF SYND, V15, P88

[3]

BIGLIONE M, 1993, J ACQ IMMUN DEF SYND, V6, P631

[4] THE HUMAN TYPE-C RETROVIRUS, HTLV, IN BLACKS FROM THE CARIBBEAN REGION, AND RELATIONSHIP TO ADULT T-CELL LEUKEMIA LYMPHOMA [J].

BLATTNER, WA ;

KALYANARAMAN, VS ;

ROBERTGUROFF, M ;

LISTER, TA ;

GALTON, DAG ;

SARIN, PS ;

CRAWFORD, MH ;

CATOVSKY, D ;

GREAVES, M ;

GALLO, RC .

INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (03) :257-264

[5] PREVALENCE OF ANTIBODIES TO HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN BLOOD-DONORS IN NORTH LONDON [J].

BRENNAN, M ;

RUNGANGA, J ;

BARBARA, JAJ ;

CONTRERAS, M ;

TEDDER, RS ;

GARSON, JA ;

TUKE, PW ;

MORTIMER, PP ;

MCALPINE, L ;

TOSSWILL, JHC .

BRITISH MEDICAL JOURNAL, 1993, 307 (6914) :1235-1239

[6] HTLV-I INFECTION IN IRAQ [J].

DENIC, S ;

NOLAN, P ;

DOHERTY, J ;

GARSON, J ;

TUKE, P ;

TEDDER, R .

LANCET, 1990, 336 (8723) :1135-1136

[7]

DETHE G, 1989, J ACQ IMMUN DEF SYND, V2, P550

[8]

FARAH S, 1996, MED PRIN PRACT, V5, P108

[9] EXTRAORDINARY HIGH-RATE OF HTLV TYPE-II SEROPOSITIVITY IN INTRAVENOUS DRUG-ABUSERS IN SOUTH-VIETNAM [J].

FUKUSHIMA, Y ;

TAKAHASHI, H ;

HALL, WW ;

NAKASONE, T ;

NAKATA, S ;

SONG, P ;

DUC, DD ;

HIEN, B ;

QUANG, NX ;

TRINH, TN ;

NISHIOKA, K ;

KITAMURA, K ;

KOMURO, K ;

VAHLNE, A ;

HONDA, M .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :637-644

[10] ISOLATION AND MOLECULAR CHARACTERIZATION OF A HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II (HTLV-II), SUBTYPE-B, FROM A HEALTHY PYGMY LIVING IN A REMOTE AREA OF CAMEROON - AN ANCIENT ORIGIN FOR HTLV-II IN AFRICA [J].

GESSAIN, A ;

MAUCLERE, P ;

FROMENT, A ;

BIGLIONE, M ;

LEHESRAN, JY ;

TEKAIA, F ;

MILLAN, J ;

DETHE, G .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :4041-4045

← 1 2 3 4 →